C4 Therapeutics (CCCC) Cash from Investing Activities (QoQ) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | C4 Therapeutics | 561.03 Mn | 325.36 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 120.01% |
| Dec 31, 2025 | -2,075.84% |
| Sep 30, 2025 | -89.50% |
| Jun 30, 2025 | 33.63% |
| Mar 31, 2025 | 113.06% |
| Dec 31, 2024 | 8,338.27% |
| Sep 30, 2024 | 101.38% |
| Jun 30, 2024 | 78.08% |
| Mar 31, 2024 | -267.15% |
| Dec 31, 2023 | -44.66% |
| Sep 30, 2023 | 281.07% |
| Jun 30, 2023 | -71.70% |
| Mar 31, 2023 | 476.59% |
| Dec 31, 2022 | -53.38% |
| Sep 30, 2022 | -40.07% |
| Jun 30, 2022 | 929.87% |
| Mar 31, 2022 | 93.26% |
| Dec 31, 2021 | 40.96% |
| Sep 30, 2021 | -410.25% |
| Jun 30, 2021 | 152.54% |
| Mar 31, 2021 | -13.96% |
| Dec 31, 2020 | -67.59% |
| Sep 30, 2020 | 68.87% |
| Jun 30, 2020 | -56,330.98% |
| Mar 31, 2020 | 7.07% |